ATRA
Atara Biotherapeutics Inc
9.70$
-0.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +472.6% | +212.6% | -86.5% | +1,404.0% | -6.3% | |
| – | – | +697.9% | +149.6% | +295.5% | +114.4% | +21.7% | +15.3% | +2,272.5% | -96.7% | +136.4% | +1.0% | |
| – | – | – | – | – | – | – | – | -1,114.8% | – | – | -7.8% | |
| – | +169.4% | +35.8% | +43.7% | +106.2% | +29.0% | +13.2% | +15.3% | -3.4% | -17.5% | -32.6% | -75.3% | |
| – | +32.4% | +46.9% | +63.1% | +72.7% | +14.3% | -19.1% | +22.4% | -13.5% | -25.3% | -21.7% | -34.2% | |
| – | +107.6% | +39.0% | +49.6% | +95.1% | +24.7% | +4.5% | +16.7% | -79.5% | +272.1% | -30.6% | -66.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -8.6% | -9.9% | -96.2% | +1,316.9% | -12.7% | -17.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -240.0% | – | – | +25.0% | +206.7% | -73.9% | +25.0% | -180.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.